Olema Pharmaceuticals ROCE Ratio 2011-2026 | OLMA

Annual ROCE Ratio Olema Pharmaceuticals

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-37.34	-34.78	-41.34	-54.16	-25.12	-6.37	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
-6.37	-54.16	-33.19

Quarterly ROCE Ratio Olema Pharmaceuticals

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-56.79	-60.79	-61.68	-48.2	-56.69	-46.26	-44.87	-38.77	-49.44	-51.62	-52.34	-33.53	-39.43	-34.67	-25.84	-15.9	-18.23	-14.65	-10.13	-3.37	-3.37	-1.04	-0.31	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
-0.31	-61.68	-33.39

ROCE Ratio of other stocks in the Biotechnology industry

Issuer	ROCE Ratio	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	2.89	-	2.43 %	$ 254 M	Germany
Amphastar Pharmaceuticals AMPH	17.8	$ 21.75	1.59 %	$ 1.02 B	USA
Aeglea BioTherapeutics AGLE	-29.3	-	-	$ 1.01 B	USA
Midatech Pharma plc MTP	-337.43	-	-18.52 %	$ 27.3 M	Britain
Alexion Pharmaceuticals, Inc. ALXN	17.36	-	-	$ 40.3 B	USA
Biophytis SA BPTS	-325.06	-	-13.47 %	$ 169 M	France
Genfit SA GNFT	-49.48	-	2.54 %	$ 160 B	France
ACADIA Pharmaceuticals ACAD	31.5	$ 22.29	1.5 %	$ 3.69 B	USA
EyeGate Pharmaceuticals, Inc. EYEG	-61.36	-	-1.52 %	$ 24.7 M	USA
Advaxis ADXS	429.74	-	-9.65 %	$ 45.9 M	USA
AIkido Pharma AIKI	-80.33	-	1.93 %	$ 17.4 M	USA
Akouos AKUS	-37.16	-	0.23 %	$ 488 M	USA
Allakos ALLK	-116.14	-	-	$ 28.6 M	USA
AlloVir ALVR	-58.56	-	4.14 %	$ 49.1 M	USA
Ampio Pharmaceuticals AMPE	-75.24	-	-11.43 %	$ 502 K	USA
Институт стволовых клеток человека ISKJ	15.18	-	-	-	Russia
Applied Molecular Transport AMTI	-209.11	-	-	$ 10.1 M	USA
Aeterna Zentaris AEZS	-29.95	-	5.93 %	$ 314 M	Canada
Brainstorm Cell Therapeutics BCLI	163.63	-	-2.5 %	$ 5.88 M	USA
Applied Therapeutics APLT	394.73	-	-	$ 8.42 M	USA
Aptinyx APTX	-163.42	-	-39.0 %	$ 4.57 M	USA
AgeX Therapeutics AGE	64924.32	-	-10.17 %	$ 12.2 K	USA
Aravive ARAV	-664.7	-	-13.39 %	$ 1.45 M	USA
Aridis Pharmaceuticals ARDS	123.77	-	17.91 %	$ 11.1 M	USA
BioNTech SE BNTX	-4.81	$ 102.75	-2.57 %	$ 27.2 B	Germany
Avenue Therapeutics ATXI	-168.29	-	-52.27 %	$ 4.45 M	USA
Applied Genetic Technologies Corporation AGTC	-60.13	-	-	$ 26.5 M	USA
Aquestive Therapeutics AQST	211.07	$ 4.1	0.37 %	$ 438 M	USA
Arcutis Biotherapeutics ARQT	-6.45	$ 23.2	-0.26 %	$ 2.95 B	USA
Ayala Pharmaceuticals AYLA	3412.47	-	-	$ 7.46 M	Israel
Autolus Therapeutics plc AUTL	-151.88	$ 1.42	-1.39 %	$ 378 M	Britain
Aptose Biosciences APTO	-46.69	-	-45.71 %	$ 1.2 M	Canada
AstraZeneca PLC AZN	11.12	-	-	$ 96.9 B	Britain
AVROBIO AVRO	10.76	-	1083.1 %	$ 745 M	USA
Can-Fite BioPharma Ltd. CANF	-146.69	$ 2.99	2.75 %	$ 4.92 M	Israel
BioDelivery Sciences International BDSI	19.77	-	-4.8 %	$ 255 M	USA
BeiGene, Ltd. BGNE	7.03	-	0.49 %	$ 251 B	Cayman-islands
Akero Therapeutics AKRO	-38.05	-	-	$ 3.67 B	USA
CureVac N.V. CVAC	-51.5	-	-	$ 867 M	Germany
bluebird bio BLUE	-125.56	-	-	$ 546 M	USA
ContraFect Corporation CFRX	545.12	-	-5.16 %	$ 5.39 M	USA
Cardiff Oncology CRDF	-107.87	$ 1.72	-0.29 %	$ 115 M	USA
BioXcel Therapeutics BTAI	52.86	$ 1.07	0.94 %	$ 13.1 M	USA
Cabaletta Bio CABA	-153.72	$ 2.96	0.17 %	$ 297 M	USA
Cara Therapeutics CARA	-127.7	-	-3.03 %	$ 260 M	USA
Esperion Therapeutics ESPR	-19.96	$ 1.95	1.83 %	$ 405 M	USA
Allena Pharmaceuticals ALNA	-252.54	-	3.16 %	$ 1.9 M	USA
CASI Pharmaceuticals CASI	-49.51	-	-	$ 35.4 M	USA